INDOCONSEIndoco Remedies Limited· PharmaceuticalsLowNeutral
Announced Thu, 15 May · 14:26 IST

Indoco Remedies Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Indoco Remedies has informed the stock exchanges about an earnings conference call to discuss its audited financial results for the quarter and year ended 31st March 2025. The call is scheduled for Thursday, 22nd May 2025 at 3:30 PM IST. Top management including Managing Director Aditi Panandikar, Jt. Managing Director Sundeep Bambolkar, and CFO Pramod Ghorpade will represent the company. The call is being hosted with research support from Dolat Capital Market, and is open to investors and analysts via dial-in numbers and a registration link.

Likely market impact

This is a routine disclosure with no immediate impact on the stock price. Investors should watch the call for management commentary on FY25 results, margin trends, and FY26 guidance, which could shape near-term sentiment.